Literature DB >> 8412549

Time preference in medical decision making and cost-effectiveness analysis.

D A Redelmeier1, D N Heller.   

Abstract

Cost-effectiveness analyses usually quantify peoples' attitudes towards delayed outcomes using the exponential discount model. The authors examined three assumptions of this model by assessing the time preferences of individuals towards hypothetical health states and calculating implicit annual discount rates. Of a random sample of medical students, house officers, and attending physicians, 121 participated, reflecting a response rate of 81%. The participants considered three temporary events (colostomy, blindness, depression) that were destined to occur at five sequentially distant times in the future (one day, six months, one year, five years, and ten years). The utility of each prospect was measured using two elicitation techniques (standard gamble and categorical scaling), and 1,394 implicit discount rates were calculated. Of all the discount rates, 62.1% equalled zero, 10.0% were less than 0.00, and 15.7% were greater than 0.10. Mean discount rates for relatively proximal time intervals tended to be larger than those for relatively more distant intervals (0.041 vs. 0.025, p < 0.01). Mean discount rates for blindness tended to be smaller than those for colostomy or depression (0.023 vs. 0.039 vs 0.037, respectively, p < 0.005). Hence, peoples' implicit discount rates are not always small positive numbers that are constant over time and the same for all settings. The authors suggest that the conventional exponential discount model may not fully characterize the time preferences held by individuals.

Entities:  

Mesh:

Year:  1993        PMID: 8412549     DOI: 10.1177/0272989X9301300306

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  12 in total

Review 1.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  The ethics of aggregation and hormone replacement therapy.

Authors:  A D Lyerly; E R Myers; R R Faden
Journal:  Health Care Anal       Date:  2001

3.  Decision biases in intertemporal choice and choice under uncertainty: testing a common account.

Authors:  Gretchen B Chapman; Bethany J Weber
Journal:  Mem Cognit       Date:  2006-04

4.  Decision tool to improve the quality of care in rheumatoid arthritis.

Authors:  Liana Fraenkel; Ellen Peters; Peter Charpentier; Blair Olsen; Lanette Errante; Robert T Schoen; Valerie Reyna
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-07       Impact factor: 4.794

5.  Can differences in breast cancer utilities explain disparities in breast cancer care?

Authors:  Mark D Schleinitz; Dina DePalo; Jeffrey Blume; Michael Stein
Journal:  J Gen Intern Med       Date:  2006-09-01       Impact factor: 5.128

6.  The economic implications of non-adherence after renal transplantation.

Authors:  Irina Cleemput; Katrien Kesteloot; Yves Vanrenterghem; Sabina De Geest
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

7.  Same patient, different advice: a study into why doctors vary.

Authors:  T Rakow; C Bull
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

Review 8.  Does temporal discounting explain unhealthy behavior? A systematic review and reinforcement learning perspective.

Authors:  Giles W Story; Ivo Vlaev; Ben Seymour; Ara Darzi; Raymond J Dolan
Journal:  Front Behav Neurosci       Date:  2014-03-12       Impact factor: 3.558

9.  How costs influence decision values for mixed outcomes.

Authors:  Deborah Talmi; Alex Pine
Journal:  Front Neurosci       Date:  2012-10-26       Impact factor: 4.677

10.  Effects of systematic asymmetric discounting on physician-patient interactions: a theoretical framework to explain poor compliance with lifestyle counseling.

Authors:  Steven R Feldman; G John Chen; Judy Y Hu; Alan B Fleischer
Journal:  BMC Med Inform Decis Mak       Date:  2002-11-25       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.